Bulgaria Pharmaceuticals & Healthcare Q4 2020
Key View:
Bulgaria continues to make progress in the streamlining of its drugs supply chain and stabilising its pricing regimes. Atthe same time, the new proposals in the 2020 budget that aim to address issues with social security and healthcare funds reflectsthe current administration's ambition to address the long-term structural problems of Bulgaria's health system. Despite this,continued socioeconomic and industry-specific factors mean that opportunities for multinational pharmaceutical companiesremain limited.
- Key View
- Bulgaria Pharmaceuticals & Healthcare Covid-19 Impact
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Bulgaria Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Industry Risk/Reward Index
- Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
- Bulgaria Innovative Pharmaceuticals Risk/Reward Index
- Regulatory Development
- Regulatory Review
- Market Overview
- Competitive Landscape
- Company Profile
- Sopharma
- Bulgaria Demographic Outlook
- Pharmaceuticals & Healthcare Glossary
- Pharmaceuticals & Healthcare Methodology
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook